Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial in a Huntington’s Disease Pre-clinical Model

Although several agents have been identified to provide therapeutic benefits in Huntington disease (HD), the number of conventionally used treatments remains limited and only symptomatic. Thus, it is plausible that the need to identify new therapeutic targets for the development of alternative and m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Mol Neurosci
Main Authors: Di Pardo, Alba, Pepe, Giuseppe, Castaldo, Salvatore, Marracino, Federico, Capocci, Luca, Amico, Enrico, Madonna, Michele, Giova, Susy, Jeong, Se Kyoo, Park, Bu-Mahn, Park, Byeong Deog, Maglione, Vittorio
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491579/
https://ncbi.nlm.nih.gov/pubmed/31068790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2019.00100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados